These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 24192014)
21. Novel vaccination approaches against equine alphavirus encephalitides. Carossino M; Thiry E; de la Grandière A; Barrandeguy ME Vaccine; 2014 Jan; 32(3):311-9. PubMed ID: 24295803 [TBL] [Abstract][Full Text] [Related]
22. Use of computational and recombinant technologies for developing novel influenza vaccines. Wong TM; Ross TM Expert Rev Vaccines; 2016; 15(1):41-51. PubMed ID: 26595182 [TBL] [Abstract][Full Text] [Related]
23. Developments of subunit and VLP vaccines against influenza A virus. Deng MP; Hu ZH; Wang HL; Deng F Virol Sin; 2012 Jun; 27(3):145-53. PubMed ID: 22684468 [TBL] [Abstract][Full Text] [Related]
25. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645 [TBL] [Abstract][Full Text] [Related]
26. Advances in the vaccination of the elderly against influenza: role of a high-dose vaccine. Sullivan SJ; Jacobson R; Poland GA Expert Rev Vaccines; 2010 Oct; 9(10):1127-33. PubMed ID: 20923264 [TBL] [Abstract][Full Text] [Related]
27. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214 [TBL] [Abstract][Full Text] [Related]
35. [Use of a microfiltration method in producing inactivated influenza vaccine]. Ivanov NB; Zhemkov VP; Gromov VI; Cherkasov AN; Shashkov LA Vopr Virusol; 1986; 31(4):404-9. PubMed ID: 3765563 [TBL] [Abstract][Full Text] [Related]
36. Advances and challenges in the development and production of effective plant-based influenza vaccines. Yusibov V; Kushnir N; Streatfield SJ Expert Rev Vaccines; 2015 Apr; 14(4):519-35. PubMed ID: 25487788 [TBL] [Abstract][Full Text] [Related]
37. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination. Ambrose CS; Wu X; Belshe RB Pediatr Infect Dis J; 2010 Sep; 29(9):806-11. PubMed ID: 20458256 [TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of inactivated and live attenuated influenza vaccines. Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of influenza vaccination in children: European perspective. Heikkinen T; Heinonen S Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481 [TBL] [Abstract][Full Text] [Related]